I0529
Anti-Interleukin-16 antibody produced in goat
affinity isolated antibody, lyophilized powder
Synonym(s):
Anti-IL-16
biological source
goat
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
lyophilized powder
species reactivity
human
technique(s)
indirect ELISA: 0.5-1.0 μg/mL
western blot: 0.1-0.2 μg/mL
UniProt accession no.
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... IL16(3603)
General description
Interleukin-16 is also known as lymphocyte chemoattractant factor (LCF) and acts as chemoattractant for human T cells. IL-16 is secreted by cells of immune system such as T cells, dendritic cells and eosinophils. It is also secreted by the non-immune cells such as endothelial cells, fibroblasts and neurons. IL-16 is biologically active in the multimeric form and binds to CD4 and CCR5 receptors. The signaling induced by IL-16 activates pathways that involve MAPK, PI3K and SAPK. The biological activities of IL-16 are important for inflammation, migration, cell cycle progression, cell proliferation, development of Th1 cells and regulation of T cell responses. IL-16 signaling is important in the pathophysiology of Crohn′s disease, HIV infection, airway inflammation in asthma and rheumatoid arthritis. Anti-Interleukin-16 antibody recognizes human IL-16.
Immunogen
recombinant human IL-16 expressed in E. coli.
Application
Anti-Interleukin-16 antibody may be used for immunoblotting at a working antibody concentration of 0.1-0.2 μg/ml. For ELISA, a working concentration of 0.5-1.0 μg/ml is recommended.
Physical form
Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Monocytes or T cells in Crohn's disease: does IL-16 allow both to play at that game?
S Schreiber
Gut, 49(6), 747-748 (2001-11-16)
Interleukin-16 in asthma.
Jing-min Deng et al.
Chinese medical journal, 119(12), 1017-1025 (2006-06-30)
W W Cruikshank et al.
Journal of leukocyte biology, 67(6), 757-766 (2000-06-17)
Interleukin 16 (IL-16) was initially described in 1982 as the first T cell chemoattractant. Through interaction with CD4, IL-16 has now been characterized as a chemoattractant for a variety of CD4+ immune cells. Recent in vivo studies have more fully
Related Content
Datasheet
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service